Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $13.8 million.

  • Cartesian Therapeutics' Total Current Liabilities fell 3551.51% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.8 million, marking a year-over-year decrease of 3551.51%. This contributed to the annual value of $23.0 million for FY2024, which is 6631.53% down from last year.
  • Latest data reveals that Cartesian Therapeutics reported Total Current Liabilities of $13.8 million as of Q3 2025, which was down 3551.51% from $12.3 million recorded in Q2 2025.
  • In the past 5 years, Cartesian Therapeutics' Total Current Liabilities ranged from a high of $95.6 million in Q3 2021 and a low of $12.3 million during Q2 2025
  • Moreover, its 5-year median value for Total Current Liabilities was $26.5 million (2023), whereas its average is $39.7 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 28780.99% in 2021, then crashed by 7518.41% in 2022.
  • Quarter analysis of 5 years shows Cartesian Therapeutics' Total Current Liabilities stood at $72.3 million in 2021, then tumbled by 65.29% to $25.1 million in 2022, then skyrocketed by 172.0% to $68.2 million in 2023, then crashed by 66.32% to $23.0 million in 2024, then plummeted by 39.92% to $13.8 million in 2025.
  • Its Total Current Liabilities was $13.8 million in Q3 2025, compared to $12.3 million in Q2 2025 and $15.0 million in Q1 2025.